Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use

Details for Australian Patent Application No. 2004201067 (hide)

Owner Novartis AG The Scripps Research Institute

Inventors Skripchenko, Yelena; Hallenbeck, Paul L.; Von Seggern, Daniel J.; Nemerow, Glen Robert; Stevenson, Susan C.

Agent Davies Collison Cave

Pub. Number AU-A-2004201067

Parent 772630

Filing date 12 March 2004

Wipo publication date 8 April 2004

International Classifications

C12N 015/85 Mutation or genetic engineering - for animal cells

C12N 015/34 Mutation or genetic engineering - Proteins from DNA viruses

C07K 014/075 Peptides having more than 20 amino acids

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

1 April 2004 Complete Application Filed

8 April 2004 Application Open to Public Inspection

  Published as AU-A-2004201067

7 September 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004201068-Improved wheelchair

2004201066-Binding acceleration techniques for the detection of analytes